Director, Advanced Molecular Detection Program
Centers for Disease Control and Prevention
Atlanta, GA
Gregory Armstrong, MD, leads CDC’s Advanced Molecular Detection (AMD) initiative, a $30m-per-year innovation and modernization program established in 2014 to bring next-generation genomic sequencing, bioinformatics, and related technologies into the public health system. The program has touched almost every area of infectious-disease public health at CDC, transforming, for example, how outbreaks are detected and investigated, and how pathogens of all types are characterized. In addition to adapting AMD technologies for public health use, the program also manages CDC’s scientific high-performance computing infrastructure, develops and oversees training of microbiologists and epidemiologists in this emerging field, and supports public-health departments across the United States to bring the technology on board.
An infectious diseases physician by background, Dr. Armstrong has particular expertise in the epidemiology of viral infectious diseases and in mathematical modeling of disease incidence and burden. Since joining CDC in 1997, he has worked in the fields of viral hepatitis and refugee health, served as chief of CDC’s viral vaccine-preventable diseases epidemiology branch, and led CDC’s component of the Global Polio Eradication Initiative during a critical intensification of the program from 2012 through 2015.
Disclosure: Nothing to disclose
Thursday, October 3
4:05 PM – 4:30 PM